Jiangsu Favored Nanotechnology Co., Ltd (SHA:688371)
China · Delayed Price · Currency is CNY 39.00
-2.40 (-5.80%)
At close: May 21, 2026
SHA:688371 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 468.38 | 498.19 | 450.45 | 304.56 | 377.09 | 397.81 |
Other Revenue | 30.98 | 30.98 | 29.01 | 4.35 | 18.47 | 12.59 |
| 499.36 | 529.17 | 479.46 | 308.91 | 395.56 | 410.4 | |
Revenue Growth (YoY) | 1.60% | 10.37% | 55.21% | -21.91% | -3.62% | 72.54% |
Cost of Revenue | 281.06 | 279.56 | 225.75 | 163.19 | 174.67 | 187.41 |
Gross Profit | 218.3 | 249.61 | 253.72 | 145.71 | 220.89 | 222.99 |
Selling, General & Admin | 158.58 | 153.42 | 125.42 | 154.96 | 151.53 | 123.56 |
Research & Development | 102.95 | 102.44 | 89.81 | 85.87 | 51.21 | 39.8 |
Other Operating Expenses | 4.31 | 4.74 | 6.35 | 1.28 | 2.29 | 1.99 |
Operating Expenses | 265.69 | 260.45 | 224.33 | 241.14 | 203.21 | 171.02 |
Operating Income | -47.39 | -10.85 | 29.38 | -95.43 | 17.67 | 51.97 |
Interest Expense | -0.14 | -0.14 | -0.19 | -0.33 | -5.03 | -3.71 |
Interest & Investment Income | 13.01 | 13.06 | 10.65 | 34.35 | 2.37 | 2.04 |
Currency Exchange Gain (Loss) | 2.84 | 2.84 | 2.78 | 3.2 | 7.91 | -0.2 |
Other Non Operating Income (Expenses) | -3.35 | -0.63 | 0.08 | -0.43 | 0.04 | -0.57 |
EBT Excluding Unusual Items | -35.03 | 4.28 | 42.71 | -58.65 | 22.97 | 49.53 |
Gain (Loss) on Sale of Investments | 19.22 | 14.84 | 7 | 3.6 | 1.49 | - |
Gain (Loss) on Sale of Assets | 0.16 | 0.1 | 3.13 | -1.31 | 1.3 | -0.03 |
Other Unusual Items | 1.16 | 1.16 | -0.63 | 6.99 | 16.5 | 3.49 |
Pretax Income | -14.49 | 20.39 | 52.22 | -49.36 | 42.25 | 52.99 |
Income Tax Expense | -17.18 | -9.82 | 7.11 | -7.81 | 8.93 | 13.68 |
Net Income | 2.69 | 30.21 | 45.11 | -41.55 | 33.32 | 39.32 |
Net Income to Common | 2.69 | 30.21 | 45.11 | -41.55 | 33.32 | 39.32 |
Net Income Growth | -94.18% | -33.02% | - | - | -15.24% | -29.23% |
Shares Outstanding (Basic) | 333 | 336 | 347 | 346 | 278 | 246 |
Shares Outstanding (Diluted) | 333 | 336 | 347 | 346 | 278 | 246 |
Shares Change (YoY) | -7.67% | -3.26% | 0.20% | 24.70% | 13.01% | 302.40% |
EPS (Basic) | 0.01 | 0.09 | 0.13 | -0.12 | 0.12 | 0.16 |
EPS (Diluted) | 0.01 | 0.09 | 0.13 | -0.12 | 0.12 | 0.16 |
EPS Growth | -93.70% | -30.77% | - | - | -25.00% | -82.41% |
Free Cash Flow | -44.67 | 4.33 | -108.29 | -340.32 | -81.17 | -226.81 |
Free Cash Flow Per Share | -0.13 | 0.01 | -0.31 | -0.98 | -0.29 | -0.92 |
Dividend Per Share | 0.050 | 0.050 | - | - | - | - |
Gross Margin | 43.72% | 47.17% | 52.92% | 47.17% | 55.84% | 54.34% |
Operating Margin | -9.49% | -2.05% | 6.13% | -30.89% | 4.47% | 12.66% |
Profit Margin | 0.54% | 5.71% | 9.41% | -13.45% | 8.42% | 9.58% |
Free Cash Flow Margin | -8.95% | 0.82% | -22.59% | -110.17% | -20.52% | -55.27% |
EBITDA | 47.26 | 83.2 | 120.97 | -30.55 | 70.73 | 89.96 |
EBITDA Margin | 9.46% | 15.72% | 25.23% | -9.89% | 17.88% | 21.92% |
D&A For EBITDA | 94.66 | 94.04 | 91.59 | 64.88 | 53.06 | 37.99 |
EBIT | -47.39 | -10.85 | 29.38 | -95.43 | 17.67 | 51.97 |
EBIT Margin | -9.49% | -2.05% | 6.13% | -30.89% | 4.47% | 12.66% |
Effective Tax Rate | - | - | 13.62% | - | 21.13% | 25.81% |
Revenue as Reported | 529.17 | 529.17 | 479.46 | 308.91 | 395.56 | 410.4 |
Advertising Expenses | - | 3.71 | 2.15 | 1.31 | 0.84 | 0.78 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.